Un-Audited Financial Results (UFR) for the first quarter ended June 30, 2025, along with the Statutory Auditors' Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Biocon (India) Ltd announced its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations rose to Rs. 166.57 lakhs, up about 69% from Rs. 98.65 lakhs in the same quarter last year. The company swung back to profitability with a net profit of Rs. 13.86 lakhs versus Rs. 9.75 lakhs in Q1 FY25, after posting a loss of Rs. 48.62 lakhs in the preceding quarter (Q4 FY25). Basic EPS stood at Rs. 0.05 versus Rs. 0.09 in Q1 FY25, the dip reflecting a larger equity base (paid-up capital rose from Rs. 1,137.28 lakhs to Rs. 2,578.28 lakhs). Statutory auditors Mayur Shah & Associates issued a clean limited review report with no qualifications or adverse observations. The company operates in a single segment.
Strong top-line growth and a return to profit after a loss-making Q4 FY25 are positive signals for shareholders, though EPS is muted due to equity dilution. The clean auditor review supports near-term confidence, but investors should watch whether the revenue momentum sustains given the small absolute scale.